Ken Griffin Citadel Advisors
Ken Griffin founded Citadel, one of the world’s largest and most successful hedge funds. Starting his trading career from his Harvard dorm room at a young age, Griffin quickly developed a keen sense for markets and built Citadel into a global powerhouse with billions in assets under management. Known for his quantitative and technology-driven strategies, Griffin has also made headlines for significant philanthropic contributions, supporting causes in education, the arts, and public institutions. Over the years, he has earned recognition as one of the preeminent figures in modern finance.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Boeing
BA
|
+$830M |
| 2 |
UnitedHealth
UNH
|
+$769M |
| 3 |
Arthur J. Gallagher & Co
AJG
|
+$691M |
| 4 |
Amazon
AMZN
|
+$654M |
| 5 |
Bank of America
BAC
|
+$634M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.23B |
| 2 |
NVIDIA
NVDA
|
+$550M |
| 3 |
Spotify
SPOT
|
+$473M |
| 4 |
Citigroup
C
|
+$460M |
| 5 |
Boston Scientific
BSX
|
+$428M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 3.13% |
| 2 | Technology | 2.97% |
| 3 | Financials | 2.19% |
| 4 | Consumer Discretionary | 2.09% |
| 5 | Industrials | 1.9% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
5726
PRA Group
PRAA
$762M
| $1.87M | ﹤0.01% |
89,699
+62,799
| +233% | +$1.34M |
|
5727
PUT
Tandem Diabetes Care
TNDM
$1.55B
| $1.87M | ﹤0.01% |
52,000
+31,400
| +152% | +$1.06M |
|
5728
CALL
Elanco Animal Health
ELAN
$11.8B
| $1.87M | ﹤0.01% |
154,600
-4,900
| -3% | -$64.1K |
|
5729
JPMorgan BetaBuilders Developed Asia Pacific-ex Japan ETF
BBAX
$6.77B
| $1.87M | ﹤0.01% |
38,388
+29,109
| +314% | +$1.5M |
|
5730
Haverty Furniture Companies
HVT
$443M
| $1.87M | ﹤0.01% |
84,067
-160,464
| -66% | -$3.8M |
|
5731
Core Laboratories
CLB
$579M
| $1.87M | ﹤0.01% |
108,069
-18,708
| -15% | -$361K |
|
|
5732
CALL
Tandem Diabetes Care
TNDM
$1.55B
| $1.87M | ﹤0.01% |
51,900
-25,300
| -33% | -$856K |
|
5733
ARK Genomic Revolution ETF
ARKG
$1.73B
| $1.87M | ﹤0.01% |
79,357
+3,107
| +4% | +$76.5K |
|
|
DMC
5734
Del Monte Corp
DMC
$1.43B
| $1.86M | ﹤0.01% |
56,145
-44,538
| -44% | -$1.43M |
|
5735
PUT
YieldMax NVDA Option Income Strategy ETF
NVDY
$1.46B
| $1.86M | ﹤0.01% |
79,800
+16,100
| +25% | +$401K |
|
5736
First Trust Value Line Dividend Fund
FVD
$8.27B
| $1.86M | ﹤0.01% |
42,688
-73,794
| -63% | -$3.34M |
|
5737
PUT
B2Gold
BTG
$6.87B
| $1.86M | ﹤0.01% |
763,300
+101,200
| +15% | +$297K |
|
5738
Kearny Financial
KRNY
$615M
| $1.86M | ﹤0.01% |
262,684
+64,482
| +33% | +$485K |
|
5739
Napco Security Technologies
NSSC
$1.36B
| $1.86M | ﹤0.01% |
52,276
+43,080
| +468% | +$1.65M |
|
5740
CALL
iShares Core Dividend Growth ETF
DGRO
$43.5B
| $1.86M | ﹤0.01% |
30,300
-228,600
| -88% | -$14.4M |
|
|
BRFS
5741
DELISTED
BRF SA
BRFS
| $1.86M | ﹤0.01% |
456,483
+105,013
| +30% | +$456K |
|
5742
PUT
ImmunityBio
IBRX
$8.39B
| $1.86M | ﹤0.01% |
725,300
+220,600
| +44% | +$919K |
|
5743
CALL
Xylem
XYL
$27.4B
| $1.86M | ﹤0.01% |
16,000
-32,400
| -67% | -$4.1M |
|
5744
PUT
Kodak
KODK
$976M
| $1.86M | ﹤0.01% |
282,400
+245,000
| +655% | +$1.39M |
|
5745
iShares iBonds Dec 2030 Term Corporate ETF
IBDV
$3.29B
| $1.86M | ﹤0.01% |
86,848
-50,532
| -37% | -$1.09M |
|
5746
PUT
Synaptics
SYNA
$4.32B
| $1.85M | ﹤0.01% |
24,300
+4,300
| +22% | +$326K |
|
5747
CALL
EVgo
EVGO
$487M
| $1.85M | ﹤0.01% |
457,900
+302,400
| +194% | +$1.92M |
|
5748
PUT
Americold
COLD
$4.14B
| $1.85M | ﹤0.01% |
86,600
+36,900
| +74% | +$893K |
|
5749
Invesco S&P MidCap 400 GARP ETF
GRPM
$505M
| $1.85M | ﹤0.01% |
16,435
+9,713
| +144% | +$1.15M |
|
5750
First Interstate BancSystem
FIBK
$3.71B
| $1.85M | ﹤0.01% |
57,044
-1,698,676
| -97% | -$55.3M |
|
Similar funds
Ken Griffin's Q4 2024 Portfolio in Review
As of Q4 2024, Ken Griffin held 15,826 positions worth $578B, up 11% from $518B the previous quarter. Its ten largest holdings account for 31% of the portfolio.
Ken Griffin deployed $35.2B of net new capital in Q4 2024, opening 1,745 new positions and adding to 6,428 existing holdings. Its largest new stake was Zoetis: 1,090,499 shares worth $178M.
By sector, the portfolio is most concentrated in Healthcare at 3.1% of assets, up from 2.9% a quarter earlier, followed by Technology and Financials.
On the sell side, the largest reduction was State Street SPDR S&P 500 ETF Trust, an estimated $1.23B trimmed.
- Ken Griffin's largest Q4 2024 buy was Zoetis: 1,090,499 shares worth $178M.
- Ken Griffin added most to Boeing in Q4 2024, an estimated $830M increase.
- Ken Griffin's biggest Q4 2024 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $1.23B.
- Ken Griffin fully exited Spotify in Q4 2024, selling an estimated $473M.
- Ken Griffin's ten largest holdings make up 31% of its $578B portfolio in Q4 2024.
- Ken Griffin opened 1,745 new positions and closed 1,423 in Q4 2024.
- Ken Griffin's portfolio value rose 11% quarter-over-quarter to $578B.
Based on Citadel Advisors's 13F filing for Q4 2024, filed 14 Feb 2025.